Former SkinHealth Systems (NASDAQ: SKIN) CRO gets $463,000 severance package
Filing Impact
Filing Sentiment
Form Type
8-K/A
Rhea-AI Filing Summary
SkinHealth Systems Inc. amended an earlier report to add details of the severance package for former Chief Revenue Officer Ronald Menezes, whose employment was terminated without cause effective May 6, 2026. The company states his departure did not involve any disagreement over financial reporting, operations, policies, or practices.
Under a Severance and General Release Agreement dated May 15, 2026, Mr. Menezes will receive total cash severance of $463,000, paid over 12 months, plus a pro-rata 2026 annual bonus payable in March 2027. He may continue health, dental, and vision coverage under COBRA with the employer portion of premiums reimbursed while severance is paid. In exchange, he provides a broad release of claims and agrees to confidentiality, non-disparagement, protection of proprietary information, return of company property, and a one-year covenant not to solicit company employees to join a competitor.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Cash severance: $463,000
Severance period: 12 months
Separation date: May 6, 2026
+3 more
6 metrics
Cash severance
$463,000
Total severance payable over 12 months from May 6, 2026
Severance period
12 months
Duration of bi-weekly cash severance payments
Separation date
May 6, 2026
Effective termination date for the Chief Revenue Officer role
Agreement date
May 15, 2026
Execution date of Severance and General Release Agreement
Bonus payment timing
March 2027
Scheduled payment date for 2026 pro-rata annual bonus
Exhibit 10.1
Severance and General Release Agreement
Filed as an exhibit to the amended current report
Key Terms
Severance and General Release Agreement, COBRA continuation coverage, pro-rata annual bonus, non-disparagement, +1 more
5 terms
Severance and General Release Agreement financial
"the executed Severance and General Release Agreement entered into by and among Hydrafacial LLC, SkinHealth Systems Inc., and Mr. Menezes"
COBRA continuation coverage financial
"may elect to continue his health, dental, and vision benefits under the Company's group health plans under COBRA continuation coverage"
pro-rata annual bonus financial
"a 2026 pro-rata annual bonus, as defined in The Beauty Health Company Amended and Restated Executive Severance Plan"
non-disparagement financial
"ongoing covenants relating to proprietary information, confidentiality of Company information, return of Company property, confidentiality of the terms of the Separation Agreement, non-disparagement"
A non-disparagement provision is a promise in an agreement that one party will not make negative public statements about the other, like a vow to avoid “badmouthing” a business or its leaders. Investors care because such promises protect reputation and can limit public criticism that might affect a company’s stock price, signal unresolved disputes, or introduce legal risk if enforcement leads to further costs or constrained disclosure.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
Why did SkinHealth Systems (SKIN) amend its 8-K about the CRO?
The amendment adds details of Ronald Menezes’ Severance and General Release Agreement. It supplements earlier disclosure on his termination as Chief Revenue Officer and files the executed agreement as Exhibit 10.1 for investors to review.
What severance will former CRO Ronald Menezes receive from SKIN?
Ronald Menezes will receive total cash severance of $463,000, paid bi-weekly over 12 months from May 6, 2026. He is also entitled to a 2026 pro-rata annual bonus, payable when regular bonuses are paid in March 2027.
Did Ronald Menezes leave SkinHealth Systems over financial reporting issues?
No. SkinHealth Systems states his termination as Chief Revenue Officer was without cause and not due to any disagreement regarding financial reporting, operations, policies, or practices. This clarification aims to address potential investor concerns about governance or accounting.
How does the SKIN separation agreement handle health benefits for the former CRO?
Starting the month after separation, Ronald Menezes may elect COBRA continuation of health, dental, and vision coverage. If he elects COBRA, the company will reimburse the employer portion of premiums while he is receiving severance benefits under the agreement.
What restrictions does the SKIN separation agreement impose on Ronald Menezes?
In exchange for severance, he agrees to release all claims and comply with ongoing covenants. These include confidentiality, protection of proprietary information, return of company property, non-disparagement, and a one-year covenant not to solicit SkinHealth employees to join a competitor.
When was the Severance and General Release Agreement with SKIN executed?
The Severance and General Release Agreement among Hydrafacial LLC, SkinHealth Systems Inc., and Ronald Menezes was executed on May 15, 2026. It formalizes severance payments, COBRA reimbursement, release of claims, and post-employment covenants following his May 6, 2026 separation.